Biotricity Inc (BTCY) Gross Profit Margin starting from the third quarter 2025 to third quarter 2024, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Biotricity Inc   (BTCY)


Biotricity Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BTCY Gross Profit Margin (Dec 31 2025)
Q3 		(Sep 30 2025)
Q2 		(Jun 30 2025)
Q1 		(Mar 31 2025)
Q4 		(Dec 31 2024)
Q3
Y / Y Revenue Change 10.19 %
Seq. Revenue Change 2.63 %
Revenue In Millions $3.99
Gross Profit Margin 81.54 %
Gross Profit Margin Total Ranking # 630
Gross Profit In Millions $3.25
Y / Y Gross Profit Change 17.64 %
Seq. Gross Profit Change 2.2 %


Commenting Third Quarter 2025 Gross Profit Margin
Biotricity Inc has managed to improve its Revenue sequentially to $3.99 millions by 2.63 % faster than Gross Profit increase of 2.2 % to $3.25 millions, this led to contraction in Gross Profit Margin to 81.54 %, but the Biotricity Inc III. Quarter Gross Profit Margin remained above company average rate of 62.62%.


Observing third quarter 2025 results within Medical Equipment & Supplies industry 18 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 571 to 630.
Learn about Gross Margin
BTCY's Gross Profit Margin third quarter 2025 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 19
Healthcare Sector # 102
Overall # 627

Gross Profit Margin Statistics
High Average Low
85.66 % 62.62 % 7.8 %
(Mar 31 2025)   (Mar 31 2019)


BTCY Gross Income Trends • More of BTCY's Profitabilty Ratios • BTCY Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
BTCY's Cumulative Gross Profit Margin
Medical Equipment & Supplies Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
BTCY's Gross Profit Margin Profitability versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for BTCY's Competitors
Gross Profit Margin Profit Margin for Biotricity Inc 's Suppliers
Gross Profit Margin Profit Margin for BTCY's Customers

You may also want to know
BTCY's Annual Growth Rates BTCY's Profitability Ratios BTCY's Asset Turnover Ratio BTCY's Dividend Growth
BTCY's Roe BTCY's Valuation Ratios BTCY's Financial Strength Ratios BTCY's Gross Profit Growth
BTCY's Roa BTCY's Inventory Turnover Ratio BTCY's Growth Rates BTCY's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2025, within Medical Equipment & Supplies Industry Gross Profit MarginDec 31 2025 MRQ Gross ProfitDec 31 2025 MRQ Revenue
Orchestra Biomed Holdings Inc   99.84 %$ 30.866  Millions$ 30.917  Millions
Soleno Therapeutics Inc  99.06 %$ 90.867  Millions$ 91.730  Millions
Longduoduo Co Ltd  98.47 %$ 0.340  Millions$ 0.345  Millions
Seastar Medical Holding Corp  97.14 %$ 0.408  Millions$ 0.420  Millions
Solana Company  96.56 %$ 5.048  Millions$ 5.228  Millions
Catheter Precision Inc   91.60 %$ 0.218  Millions$ 0.238  Millions
Electrocore Inc   88.39 %$ 8.170  Millions$ 9.243  Millions
Nexalin Technology Inc   87.77 %$ 0.151  Millions$ 0.172  Millions
Sanara Medtech Inc   86.51 %$ 25.645  Millions$ 29.645  Millions
Baird Medical Investment Holdings Limited  86.29 %$ 18.884  Millions$ 21.884  Millions
Inspire Medical Systems inc   85.98 %$ 233.006  Millions$ 271.006  Millions
Delcath Systems Inc   85.48 %$ 17.718  Millions$ 20.728  Millions
Neuraxis Inc   85.40 %$ 0.827  Millions$ 0.968  Millions
Ceribell Inc   84.40 %$ 21.643  Millions$ 25.643  Millions
Pulsenmore Ltd   84.16 %$ 10.559  Millions$ 12.547  Millions
Mimedx Group Inc   83.86 %$ 99.040  Millions$ 118.095  Millions
Cvrx inc   82.17 %$ 13.825  Millions$ 16.825  Millions
Sight Sciences Inc   81.64 %$ 17.788  Millions$ 21.788  Millions
Biotricity Inc   81.54 %$ 3.251  Millions$ 3.988  Millions
Avita Medical Inc   81.24 %$ 14.311  Millions$ 17.616  Millions
Treace Medical Concepts Inc   80.62 %$ 50.401  Millions$ 62.519  Millions
Vycor Medical Inc   80.45 %$ 0.335  Millions$ 0.417  Millions
Fonar Corporation  80.37 %$ 20.533  Millions$ 25.547  Millions
Heartflow Inc   79.51 %$ 39.063  Millions$ 49.130  Millions
Trisalus Life Sciences Inc   79.23 %$ 11.443  Millions$ 14.443  Millions
Electromed Inc   78.74 %$ 14.819  Millions$ 18.819  Millions
Inmode Ltd   78.54 %$ 290.970  Millions$ 370.495  Millions
Edwards Lifesciences Corporation  78.10 %$ 1,226.600  Millions$ 1,570.600  Millions
Guided Therapeutics Inc   77.46 %$ 0.457  Millions$ 0.590  Millions
Neuropace Inc   77.42 %$ 20.578  Millions$ 26.578  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.